SEC Form 4 · accession 0001209191-17-016189
BIOTELEMETRY, INC. · BEAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Hrenko
Officer — SVP - Human Resources
Period of report
Feb 27, 2017
Accepted (ET)
Mar 1, 2017 · 8:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 27, 2017 | S | 16,731 | $25.97 | D | 20,518 | D | |
| Common Stock | Feb 27, 2017 | M | 1,138 | $9.57 | A | 21,656 | D | |
| Common StockF3 | Feb 27, 2017 | S | 1,138 | $25.95 | D | 20,518 | D | |
| Common Stock | Feb 27, 2017 | M | 1,773 | $9.57 | A | 22,291 | D | |
| Common StockF3 | Feb 27, 2017 | S | 1,773 | $25.95 | D | 20,518 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $9.57 | Feb 27, 2017 | M | 1,773 | D | Dec 31, 2016 | Feb 15, 2025 | Common Stock | 1,773 | 0 | D |
| Stock Options | $9.57 | Feb 27, 2017 | M | 1,138 | D | Dec 31, 2016 | Feb 15, 2025 | Common Stock | 1,138 | 0 | D |
Explanation of responses
- F1Represents sales pursuant the reporting person's retirement.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.75 to $26.30, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.60 to $26.30, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this Form 4.